Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Profit After Tax Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT Growth (1y) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 16.74%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -123.42%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 9.23%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 54.57%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 25.41%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 20.96%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -113.49%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn -7.61%
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn 93.20%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 93.20%
Dec 31, 2025 -15,916.67%
Sep 30, 2025 74.36%
Jun 30, 2025 22.04%
Mar 31, 2025 -972.43%
Dec 31, 2024 100.99%
Sep 30, 2024 -287.57%
Jun 30, 2024 -198.67%
Mar 31, 2024 -854.66%
Dec 31, 2023 -9.12%
Sep 30, 2023 63.61%
Jun 30, 2023 -140.25%
Mar 31, 2023 109.04%
Dec 31, 2022 -273.36%
Sep 30, 2022 -1,902.94%
Jun 30, 2022 693.90%
Mar 31, 2022 -928.40%
Dec 31, 2021 256.26%
Sep 30, 2021 84.52%
Jun 30, 2021 74.07%
Mar 31, 2021 85.19%
Dec 31, 2020 -211.82%
Sep 30, 2020 58.09%
Jun 30, 2020 -540.08%
Mar 31, 2020 -90.55%
Dec 31, 2019 -83.36%
Sep 30, 2019 -923.44%
Jun 30, 2019 83.13%
Mar 31, 2019 59.49%
Dec 31, 2018 30,145.45%
Sep 30, 2018 60.31%
Jun 30, 2018 -137.28%
Mar 31, 2018 -448.78%
Dec 31, 2017 99.17%
Sep 30, 2017 60.62%
Jun 30, 2017 13.46%
Mar 31, 2017 -67.61%
Dec 31, 2016 92.30%
Sep 30, 2016 -93.39%
Jun 30, 2016 -304.30%
Mar 31, 2016 54.60%
Dec 31, 2015 -90,110.53%
Sep 30, 2015 -233.81%
Jun 30, 2015 -65.85%
Mar 31, 2015 -294.85%
Dec 31, 2014 97.49%
Sep 30, 2014 1,391.84%
Jun 30, 2014 649.46%
Mar 31, 2014 648.96%
Dec 31, 2013 -164.51%
Sep 30, 2013 63.16%
Jun 30, 2013 -112.00%
Mar 31, 2013 -91.04%
Dec 31, 2012 58.81%
Sep 30, 2012 -575.00%
Jun 30, 2012 13.14%
Mar 31, 2012 -36.04%
Dec 31, 2011 -66.19%
Sep 30, 2011 -99.78%
Jun 30, 2011 -27.21%